963196

Akrimax Pharmaceuticals, LLC — FEI 3007295270

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 17, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cranford, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)